Table 3

Summary of toxicities encountered during T + E therapy

Cycle 1, no. (%) of 84 patientsTotal, no. (%) of 273 patients
Hospitalizations 49 (58) 66 (24) 
Documented infections 30 (36) 50 (18) 
    Skin/cellulitis 
    Pneumonia 18 23 
    Sinusitis 
    Gastrointestinal 
    Genitourinary 
    Bacteremia 10 
Neutropenic fever 20 (24) 31 (11) 
Drug-related toxicities   
    Neurotoxicity (grade 1-4) 19* 22 
    Oral mucositis (> grade 2) 
    Gastrointestinal (> grade 2) 
    Hyperbilirubinemia (> grade 2) 10 16 
    Renal (> grade 2) 14 17 
    Dehydration (> grade 2) 13 16 
    Rash (> grade 2) 
    Fatigue (> grade 2) 15 26 
    Cardiac (grade 1-5) 3 6§ 
Death 10 (12) 14 (5) 
    Infection 
        Blood 
        Lung 
    Cardiac 
    Multiorgan 
Cycle 1, no. (%) of 84 patientsTotal, no. (%) of 273 patients
Hospitalizations 49 (58) 66 (24) 
Documented infections 30 (36) 50 (18) 
    Skin/cellulitis 
    Pneumonia 18 23 
    Sinusitis 
    Gastrointestinal 
    Genitourinary 
    Bacteremia 10 
Neutropenic fever 20 (24) 31 (11) 
Drug-related toxicities   
    Neurotoxicity (grade 1-4) 19* 22 
    Oral mucositis (> grade 2) 
    Gastrointestinal (> grade 2) 
    Hyperbilirubinemia (> grade 2) 10 16 
    Renal (> grade 2) 14 17 
    Dehydration (> grade 2) 13 16 
    Rash (> grade 2) 
    Fatigue (> grade 2) 15 26 
    Cardiac (grade 1-5) 3 6§ 
Death 10 (12) 14 (5) 
    Infection 
        Blood 
        Lung 
    Cardiac 
    Multiorgan 
*

Seven grade 1, 7 grade 2, 3 grade 3, and 2 grade 4.

One grade 2, 1 grade 3, and 1 grade 5.

Seven grade 1, 9 grade 2, 3 grade 3, and 3 grade 4.

§

One grade 2, 3 grade 3, and 2 grade 5.

or Create an Account

Close Modal
Close Modal